| 21/50 | US=105 / Câncer Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. T-regulatory cell manipulation in tumor immunotherapy. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 189-204. ISBN 978-0-470-07474-9. CANCER; IMUNOTERAPIA; CELULAS T REGULADORAS; LEUCOCITOS VASCULARES |
| 22/50 | US=105 / Câncer Augustine M, Chen L. Cancer immunotherapy: untapping the potential of costimulatory molecules beyond CTLA-4. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 243-68. ISBN 978-0-470-07474-9. CANCER; IMUNOTERAPIA; MOLECULAS CO-ESTIMULATORIAS; CTLA-4; PD-1; B7-H1; B7-DC; CD137 |
| 23/50 | US=105 / Câncer Kim-Schulze S, Ornstein M, Kaufman HL. Advances in immune monitoring strategies for cancer vaccines and immunotherapy. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 271-89. ISBN 978-0-470-07474-9. |
| 24/50 | US=103 / Câncer Belimezi M. Cancer immunotherapy. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 283-304. ISBN 978-0-470-72303-6. CANCER; IMUNOTERAPIA; BASE MOLECULAR DA IMUNOTERAPIA; ANTICORPOS MONOCLONAIS RECOMBINANTES; IMUNOTERAPIA CELULAR; VACINAS |
| 25/50 | US=13 / Biol/Mol Pecorino L. Cancer in the future: focus on diagnostics and immunotherapy. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 275-95. ISBN 978-0-19-921148-7. CANCER; PERSPECTIVAS; IMUNOTERAPIA; VACINA; MICROARRAYS; PERFIL DE EXPRESSAO; DIAGNOSTICO; PROGNOSTICO; IMAGEM; BIOINFORMATICA; NANOTECNOLOGIA |
| 26/50 | US=14 / Câncer al-Ramadi BK, Fernandez-Cabezudo MJ, El-Hasasna H, Al-Salam S, Attoub S, Xu D, Chouaib S. Attenuated bacteria as effectors in cancer immunotherapy. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 351-7. ISBN 978-1-57331-700-9. CANCER; IMUNOTERAPIA; BAIXA ANTIGENICIDADE; TUMORIGENICIDADE ALTA; IL-2 SALMONELLA |
| 27/50 | US=18 / Dermatologia Hengge UR. Topical immunotherapy. In: Schwartz RA. Skin cancer: recognition and management. 2nd ed. Massachusetts: Blackwell Science, 2008. p. 468-76. ISBN 978-1-4051-5961-6. IMUNOTERAPIA; AVALIACAO DA IMUNOCOMPETENCIA; IMUNOMODULADORES TOPICOS; QUERATOSE ACTINICA; CARCINOMA BASOCELULAR |
| 28/50 | US=23-C / Câncer Marits P, Karlsson M, Thorn M, Winqvist O. Sentinel node-based immunotherapy of colon cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 291-312. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; TRATAMENTO; CANCER DE COLON; IMUNOTERAPIA; LINFONODO SENTINELA; RESPOSTA IMUNE |
| 29/50 | US=49-C / Câncer Vulink A, Radford KJ, Melief C, Hart DNJ. Dendritic cells in cancer immunotherapy. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2008. p. 363-407. ISBN 978-0-12-3742247. CANCER; CELULAS DENDRITICAS; IMUNOTERAPIA; BIOLOGIA CELULAR DAS CELULAS DENDRITICAS; VACINA |
| 30/50 | US=64 / Câncer Dhodapkar MV. Immunobiology and immunotherapy of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. IMUNOLOBIOLOGIA DO MIELOMA MULTIPLO; IMUNOTERAPIA DO MIELOMA MULTIPLO |
| 31/50 | US=111-A / Câncer Meisel R, Troger A, Moritz T, Dilloo D. Models for immunotherapy and cancer vaccines. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 1043-54. ISBN 978-0-470-01852-1. |
| 32/50 | US=16 / Urologia Lee C, Shah A, Liu V, Park I, Wong L, Huang X, Huang L, Fermin T, Jang T, Kundu S, Zhou V, Zhang Q, Smith N. Biology and imaging: role of transformig growth factor-B in immunotherapy of prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 165-74. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; FATOR DE TRANSFORMACAO DO CRESCIMENTO BETA; IMUNOTERAPIA; CANCER DE PROSTATA; TRANSFERENCIA ADOTIVA; CELULAS T CITOLITICAS; IMUNOTERAPIA; SINALIZACAO TGF-B |
| 33/50 | US=49 / Câncer Ringdén O. Immunotherapy by allogeneic stem cell transplantation. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 25-60. ISBN 978-0-12-006697-1. IMUNOTERAPIA; TRANSPLANTE DE CELULAS-TRONCO ALOGENICO; DOENCA DO ENXERTO-VERSUS-HOSPEDEIRO; ENXERTO-VERSUS-LEUCEMIA; CELULAS NK; ENXERTO CONTRA O CANCER; CELULAS-TRONCO MESENQUIMAIS |
| 34/50 | US=57-B / Biol/Mol Weinberg RA. Crowd control: tumor immunology and immunotherapy. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 655-724. ISBN 0-8153-4078-8. IMUNOLOGIA DE TUMORES; IMUNOTERAPIA; MOLECULAS DE ANTICORPO POR NEUTRALIZACAO; LINFOCITOS T CITOTOXICOS; IMUNES ANTI-TUMORAIS, ESENVOLVIMENTO DE RESPOSTAS |
| 35/50 | US=76 / Biol/Mol Jäger D. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX). In: Sioud M. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 319-26. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. IMUNOTERAPIA; ANALISE SOROLOGICA DE CDNA RECOMBINANTE TUMOR; SEREX; REVERTER IMUNOLOGIA; ANTIGENIOS TUMORAIS |
| 36/50 | US=10 / Biol/Mol Yee C. Tumor immunity and immunotherapy. In: Pelengaris S, Khan M. The molecular biology of cancer. Oxford: Blackwell, 2006. p. 389-410. ISBN 978-1-4051-1814-9. IMUNIDADE DO TUMOR; IMUNOTERAPIA; CELULAS EFETORAS NA IMUNIDADE TUMOR; ANTIGENIOS TUMORAIS; TERAPIA ESPECIFICA PARA O ANTIGENIO DE CANCER; TERAPIA DE CITOQUINAS DE CANCER; EVASAO IMUNE TUMOR |
| 37/50 | US=37 / Câncer Schirrmacher V. Tumor vaccination and antibody-mediated immunotherapy. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 226-35. ISBN 978-1-5889-0323-0. CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; VACINA; IMUNOTERAPIA MEDIADA POR ANTICORPOS; IMUNOTERAPIA ESPECIFICA ATIVA; ANTICORPOS MONOCLONAIS; IMUNOTERAPIA PASSIVA; ESTUDOS CLINICOS |
| 38/50 | US=49-A / Câncer Sentman CL, Barber MA, Barber A, Zhang T. NK cell receptors as tools in cancer immunotherapy. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2006. p. 249-92. ISBN 978-0-12-006695-7. |
| 39/50 | US=61 / Câncer DeLeo AB. The role of hormones, growth factors, and oncogenes: p53-based immunotherapy of cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 491-505. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 40/50 | US=16 / Ortopedia Plunkett TA, Miles DW. Systemic treatments: immunotherapy. In: Jasmin C, Coleman RE, Coia LR, Capanna R, Saillan G. Textbook of bone metastases. New Jersey: John Wiley & Sons, 2005. p. 313-22. ISBN 978-0-471-87742-5. IMUNOTERAPIA; MELANOMA; NEOPLASIAS RENAIS; VACINAS ANTICANCER; METASTASE NEOPLASICA; NEOPLASIAS OSSEAS |